Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
3.000
-0.130 (-4.15%)
At close: Nov 16, 2026, 4:00 PM EST
2.960
-0.040 (-1.33%)
After-hours: Nov 16, 2026, 7:30 PM EST

Coya Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
4.697.953.556--
Revenue Growth
17.59%123.57%-40.79%---
Gross Profit
-12.05-8.79-8.310.5-4.41-
Operating Income
-29.86-20.27-17.22-7.36-9.29-4.87
Net Income
-30.17-21.23-14.88-7.99-12.24-4.89
Earnings Per Share
-1.40-1.27-0.98-0.79-4.73-1.89
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
35.846.8238.3432.635.934.34
Total Debt
----12.97-
Net Cash (Debt)
35.846.8238.3432.63-7.034.34
Net Cash Growth
27.27%22.13%17.51%---50.23%
Net Cash Per Share
1.662.802.523.21-2.711.68

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-21.83-10.74-10.29-11.19-7.24-3.9
Capital Expenditures
-0.39-----0.14
Free Cash Flow
-22.22-10.74-10.29-11.19-7.24-4.04
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-256.89%-110.61%-233.86%8.34%--
Operating Margin
-636.77%-255.05%-484.65%-122.62%--
Pretax Margin
-643.38%-267.10%-438.96%-121.02%--
Profit Margin
-643.45%-267.14%-418.70%-133.08%--
FCF Margin
-473.89%-135.16%-289.50%-186.41%--

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
15.0115.2726.9417.78--